These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3063366)

  • 21. Is the "comb over" dying? A mouse model for male pattern baldness (androgenic alopecia).
    Walker WH
    Endocrinology; 2010 May; 151(5):1981-3. PubMed ID: 20410210
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hormonal interaction and hair growth].
    Hoffmann R
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):787-92. PubMed ID: 12223960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New topical antiandrogenic formulations can stimulate hair growth in human bald scalp grafted onto mice.
    Sintov A; Serafimovich S; Gilhar A
    Int J Pharm; 2000 Jan; 194(1):125-34. PubMed ID: 10601691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice.
    De Brouwer B; Tételin C; Leroy T; Bonfils A; Van Neste D
    Br J Dermatol; 1997 Nov; 137(5):699-702. PubMed ID: 9415227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia.
    Krausz A; Friedman AJ
    J Drugs Dermatol; 2013 Nov; 12(11):1297-300. PubMed ID: 24358489
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of androgenetic alopecia.
    Bolduc C; Shapiro J
    Am J Clin Dermatol; 2000; 1(3):151-8. PubMed ID: 11702296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Special symposium on Dermatological Therapy: V. Diseases of the appendages. Alopecia and hirsutism.
    Dawber RP
    Clin Exp Dermatol; 1982 Mar; 7(2):177-82. PubMed ID: 7083623
    [No Abstract]   [Full Text] [Related]  

  • 28. Alopecia and hirsuties. Current concepts in pathogenesis and management.
    Barth JH
    Drugs; 1988 Jan; 35(1):83-91. PubMed ID: 3278880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrinology Update: Hirsutism.
    Heidelbaugh JJ
    FP Essent; 2016 Dec; 451():17-24. PubMed ID: 27936531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.
    Wessagowit V; Tangjaturonrusamee C; Kootiratrakarn T; Bunnag T; Pimonrat T; Muangdang N; Pichai P
    Australas J Dermatol; 2016 Aug; 57(3):e76-82. PubMed ID: 26010505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
    Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
    Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches to the management of common baldness.
    Sommer M; Wilson C
    Int J Clin Pract; 1999; 53(5):381-5. PubMed ID: 10695105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A risk-benefit assessment of pharmacological therapies for hirsutism.
    Carmina E
    Drug Saf; 2001; 24(4):267-76. PubMed ID: 11330656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hirsutism: pathogenesis and treatment.
    Casey JH
    Aust N Z J Med; 1980 Apr; 10(2):240-5. PubMed ID: 6930219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.
    Swiglo BA; Cosma M; Flynn DN; Kurtz DM; Labella ML; Mullan RJ; Erwin PJ; Montori VM
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1153-60. PubMed ID: 18252786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Buzney E; Sheu J; Buzney C; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the available pharmacotherapy for the treatment of hirsutism.
    Asfour L; Kazmi A; Sinclair R
    Expert Opin Pharmacother; 2023 May; 24(7):803-813. PubMed ID: 36995154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
    Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
    Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.